Laparoscopic Sleeve Gastrectomy With and Without Omentectomy

Completed · Phase 3

Conditions studied: Morbid Obesity

In brief

* The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity. * The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by sleeve gastrectomy and omentectomy (omentum or intra-abdominal fat removal) will provide clinical and metabolic benefits for morbidly obese patients.

Key facts

Study ID

NCT00434525

Run by

North Texas Veterans Healthcare System

People needed

30

Starts

2008-01-01

Expected to finish

2009-12-01

Last updated by the study team

2009-12-15

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Morbidly obese VETERANS ONLY (BMI>35 with comorbidities or BMI>40)
• Age > 18

You may not qualify if…

• Pregnancy
• Uncontrolled medical or psychiatric conditions
• Previous bariatric procedure

Where it is running

• VA North Texas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.